Skip to main content
Premium Trial:

Request an Annual Quote

BioTrove Raises $13.7M in Second Round of Financing

NEW YORK, April 15 (GenomeWeb News) - Biotrove has raised $13.7 million in a second round of financing, the company said today.


The Woburn, Mass.-based company will use the cash to commercialize its Living Chip SNP genotyping chip and Momentum assay development and screening platforms. BioTrove will also use the funds to support construction of a 10,000-square-foot manufacturing facility.


The round follows a first round of financing, announced in January. New investors in the second round included Echelon Ventures and Fletcher Spaght.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.